In the press

James Carthew comments on SEIT wind-down in Investment Week

Biotech trusts top performance charts in February

James Carthew comments on SEIT’s decision to wind down in Linus Uhlig’s article:

“I am in favour of SEIT’s decision to pursue a managed wind down as long as it does not prioritise speedy returns of capital over achieving decent prices for its assets. The statement makes it clear that it is not easy to make disposals in the current environment – so let us not rush things.”

Read the article here